Mandating Advisable and Informed Locations and Solutions Act or the MAILS ActThis bill requires the U.S. Postal Service (USPS) to (1) establish a formal process for a local government official to request a new post office, and (2) modify how it communicates with local officials and the public about certain topics.Specifically, USPS must modify existing regulations with respect to temporary relocations of postal retail services for holidays, special events, overflow business, and commemorative events. USPS may not implement any such temporary relocation for more than two days unless it first collects and considers community input. USPS must also provide specified notifications to local officials and the public, periodic updates to local officials, and a public presentation about such a relocation.
Ensuring Accurate and Complete Abortion Data Reporting Act of 2025This bill requires states, as a condition of federal payment under Medicaid for family planning services, to report certain abortion data to the Centers for Disease Control and Prevention (CDC). (Currently, reporting is voluntary.) The CDC must develop standardized questions for states with respect to specified variables (e.g., maternal demographics and methods of abortion).
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)